IL-37 expression reduces lean body mass in mice by reducing food intake

Eline N. Kuipers, Andrea D. van Dam, Dov B. Ballak, Ellemiek A. de Wit, Charles A. Dinarello, Rinke Stienstra, Janna A. van Diepen, Patrick C.N. Rensen, Mariëtte R. Boon*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)


The human cytokine interleukin (IL)-37 is an anti-inflammatory member of the IL-1 family of cytokines. Transgenic expression of IL-37 in mice protects them from diet-induced obesity and associated metabolic complications including dyslipidemia, inflammation and insulin resistance. The precise mechanism of action leading to these beneficial metabolic effects is not entirely known. Therefore, we aimed to assess in detail the effect of transgenic IL-37 expression on energy balance, including food intake and energy expenditure. Feeding homozygous IL-37 transgenic mice and wild-type (WT) control mice a high-fat diet (HFD; 45% kcal palm fat) for 6 weeks showed that IL-37 reduced body weight related to a marked decrease in food intake. Subsequent mechanistic studies in mice with heterozygous IL-37 expression versus WT littermates, fed the HFD for 18 weeks, confirmed that IL-37 reduces food intake, which led to a decrease in lean body mass, but did not reduce fat mass and plasma lipid levels or alterations in energy expenditure independent of lean body mass. Taken together, this suggests that IL-37 reduces lean body mass by reducing food intake.

Original languageEnglish
Article number2264
JournalInternational Journal of Molecular Sciences
Issue number8
Publication statusPublished - 2 Aug 2018


  • Energy metabolism
  • Food intake
  • High fat diet
  • IL-37

Fingerprint Dive into the research topics of 'IL-37 expression reduces lean body mass in mice by reducing food intake'. Together they form a unique fingerprint.

Cite this